Catatonia and Cannabis Withdrawal: a case report
Document type :
Article dans une revue scientifique: Éditorial
PMID :
Permalink :
Title :
Catatonia and Cannabis Withdrawal: a case report
Author(s) :
Caudron, Mathieu [Auteur]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Rolland, Benjamin [Auteur]
Deheul, Sylvie [Auteur]
Geoffroy, Pierre-Alexis [Auteur]
Thomas, Pierre [Auteur]
Sciences Cognitives et Sciences Affectives (SCALab) - UMR 9193
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Amad, Ali [Auteur]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Sciences Cognitives et Sciences Affectives (SCALab) - UMR 9193
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Rolland, Benjamin [Auteur]
Deheul, Sylvie [Auteur]
Geoffroy, Pierre-Alexis [Auteur]
Thomas, Pierre [Auteur]

Sciences Cognitives et Sciences Affectives (SCALab) - UMR 9193
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Amad, Ali [Auteur]

Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Laboratoire Sciences Cognitives et Sciences Affectives - UMR 9193 [SCALab]
Sciences Cognitives et Sciences Affectives (SCALab) - UMR 9193
Journal title :
Substance Abuse
Abbreviated title :
Subst. Abus.
Volume number :
37
Pages :
188-189
Publication date :
2015-08-06
ISSN :
1547-0164
English keyword(s) :
GABA/glutamate balance
Cannabis withdrawal
catatonia
Mesh:Lorazepam/therapeutic use
Mesh:Marijuana Abuse/drug therapy
Mesh:Hypnotics and Sedatives/therapeutic use
Mesh:Humans
Mesh:Excitatory Amino Acid Antagonists/therapeutic use
Mesh:Catatonia/drug therapy
Mesh:Catatonia/diagnosis*
Mesh:Catatonia/complications*
Mesh:Adult
Mesh:Marijuana Abuse/complications*
Mesh:Substance Withdrawal Syndrome/complications*
Mesh:Substance Withdrawal Syndrome/diagnosis*
Mesh:Substance Withdrawal Syndrome/drug therapy
Mesh:Memantine/therapeutic use
Mesh:Male
Cannabis withdrawal
catatonia
Mesh:Lorazepam/therapeutic use
Mesh:Marijuana Abuse/drug therapy
Mesh:Hypnotics and Sedatives/therapeutic use
Mesh:Humans
Mesh:Excitatory Amino Acid Antagonists/therapeutic use
Mesh:Catatonia/drug therapy
Mesh:Catatonia/diagnosis*
Mesh:Catatonia/complications*
Mesh:Adult
Mesh:Marijuana Abuse/complications*
Mesh:Substance Withdrawal Syndrome/complications*
Mesh:Substance Withdrawal Syndrome/diagnosis*
Mesh:Substance Withdrawal Syndrome/drug therapy
Mesh:Memantine/therapeutic use
Mesh:Male
HAL domain(s) :
Sciences du Vivant [q-bio]
Sciences cognitives
Sciences cognitives
English abstract : [en]
BACKGROUND: Catatonia is a severe motor syndrome found in approximately 10% of all acute psychiatric hospital admissions. It can occur in various psychiatric diseases. We report the first case report of catatonia during ...
Show more >BACKGROUND: Catatonia is a severe motor syndrome found in approximately 10% of all acute psychiatric hospital admissions. It can occur in various psychiatric diseases. We report the first case report of catatonia during cannabis withdrawal. CASE PRESENTATION: Mr. A, a 32-year-old man, reported to have daily smoked approximately 20 grams of cannabis since aged 11 years. Mr. A was incarcerated and was reported three weeks later to the medical department for having completely ceased talking and eating. At admission in our department, the patient presented with classical catatonia symptoms (Bush-Francis Catatonia Rating Scale (BFCRS) score = 39/69). All laboratory results and brain MRI were normal. Six weeks after his admission and treatments by lorazepam and memantine, his BFCRS score was 0/69. DISCUSSION: This single-case study highlights the previously under-reported emergence of physical and motor symptoms following cannabis withdrawal. Pathophysiological aspects of abrupt cannabis cessation contributing to GABA/glutamate balance dysregulation and to catatonia are discussed.Show less >
Show more >BACKGROUND: Catatonia is a severe motor syndrome found in approximately 10% of all acute psychiatric hospital admissions. It can occur in various psychiatric diseases. We report the first case report of catatonia during cannabis withdrawal. CASE PRESENTATION: Mr. A, a 32-year-old man, reported to have daily smoked approximately 20 grams of cannabis since aged 11 years. Mr. A was incarcerated and was reported three weeks later to the medical department for having completely ceased talking and eating. At admission in our department, the patient presented with classical catatonia symptoms (Bush-Francis Catatonia Rating Scale (BFCRS) score = 39/69). All laboratory results and brain MRI were normal. Six weeks after his admission and treatments by lorazepam and memantine, his BFCRS score was 0/69. DISCUSSION: This single-case study highlights the previously under-reported emergence of physical and motor symptoms following cannabis withdrawal. Pathophysiological aspects of abrupt cannabis cessation contributing to GABA/glutamate balance dysregulation and to catatonia are discussed.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
CHU Lille
CNRS
Inserm
Université de Lille
CNRS
Inserm
Université de Lille
Research team(s) :
Équipe Psychiatrie & Croyance (PsyCHIC)
Submission date :
2019-02-13T14:50:50Z
2019-11-26T16:51:27Z
2019-11-26T16:51:27Z